ArticleClinical and experimental medicine2018

MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.

Jie Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.